Researcher
Johan Maertens
- Disciplines:Biochemistry and metabolism, Microbiology, Systems biology, Laboratory medicine, Medical biochemistry and metabolism
Affiliations
- Laboratory of Clinical Microbiology (Division)
Member
From1 Oct 2014 → Today - Department of Microbiology, Immunology and Transplantation (Department)
Member
From1 Oct 2013 → 30 Sep 2014 - Woman and Child (Division)
Member
From1 Apr 2013 → 30 Sep 2013
Projects
1 - 10 of 11
- Insights in febrile neutropenia (SAFE study) and clinical and translational insights in (invasive) mold infections and mycology, with the focus on Hematologic patients.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Optimization and validation of collateral sensitivity based alternative treatment strategies for multidrug resistant CandidemiaFrom1 Oct 2022 → TodayFunding: IOF - technology validation in lab
- SAFE study: a randomized non-inferiority trialFrom1 Oct 2022 → TodayFunding: Foundations, funds and other with scientific goal
- Improving prevention and treatment strategies concerning opportunistic infections in immunocompromised hematologic patientsFrom14 Sep 2020 → TodayFunding: Foundations, funds and other with scientific goal
- Clonal evolution and biology of co-operative oncogenic events in acute lymphoblastic leukemia.From1 Oct 2018 → 30 Sep 2023Funding: Fund Recuperation Fiscal Exemption
- Fast diagnosis of opportunistic respiratory infections trough exhaled breath analysisFrom1 Oct 2017 → 30 Sep 2020Funding: FWO Applied Biomedical Research (TBM)
- Triazole-resistance in Aspergillus fumigatus: evolving epidemiology and influence on disease progression.From15 Mar 2017 → 2 Dec 2021Funding: BOF - doctoral mandates, BOF - Doctoral projects
- Faster to the fungus: rapid diagnostic and prognostic tests for invasive fungal diseasesFrom1 Aug 2016 → 9 Oct 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
- Rethinking 'Care after Cure' in allogeneic hematopoietic stem cell transplantation using e-Health and patient reported outcomesFrom1 Sep 2015 → 14 Nov 2019Funding: Own budget, for example: patrimony, inscription fees, gifts
- Assessment of the impact of emerging azole resistance mechanisms on treatment response of invasive pulmonary aspergillosis using non-invasive imaging in experimental Aspergillus infection models.From1 Jan 2015 → 31 Dec 2018Funding: FWO research project (including WEAVE projects)
Publications
351 - 360 of 536
- Validation and comparison of prognostic systems in secondary (post-PV/ET) myelofibrosis after allogeneic stem-cell transplantation. A report of the CMWP-EBMT
Authors: Nico Gagelmann, Dirk-Jan Eikema, Linda Koster, Christine Wolschke, Renate Arnold, Lothar Kanz, Grant McQuaker, Ibrahim Yakoub-Agha, Thierry Lamy, Gerard Socie, et al.
Pages: 250 - 251 - Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS
Authors: Johan Maertens
Pages: 534 - 543 - Superior Outcomes with Myeloablative versus Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Secondary Acute Myeloid Leukemia with Prior Solid Tumor: An ALWP of EBMT Study
Authors: Catherine Lee, Myriam Labopin, Dietrich Beelen, Juergen Finke, Didier Blaise, Arnold Ganser, Maija Itala-Remes, Patrice Chevallier, Helene Labussiere-Wallet, Johan Maertens, et al.
Pages: 20 - 21 - Comparative outcomes for matched and mismatched (haplo) family donors for Myelodysplastic syndromes: Results from the EBMT Chronic Leukaemia Working Party
Authors: Kavita Raj, Dirk-Jan Eikema, Linda Koster, Maria Teresa Van Lint, Didier Blaise, Arnon Nagler, Dietrich Beelen, Gerard Socie, Yener Koc, Ibrahim Yakoub-Agha, et al.
Pages: 137 - 138 - Curative allogeneic transplant for blast crisis systemic mastocytosis
Authors: Johan Maertens
Pages: S307 - S307 - Allogeneic Stem Cell Transplantation for FLT3-Mutated Acute Myeloid Leukemia: In vivo T-Cell Depletion and Posttransplant Sorafenib Maintenance Improve Survival. A Retrospective Acute Leukemia Working Party-European Society for Blood and Marrow Transplant Study.
Authors: Johan Maertens
Pages: 58 - 74 - Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7)
Authors: Malgorzata Mikulska, Simone Cesaro, Hugues de Lavallade, Roberta Di Blasi, Sigrun Einarsdottir, Giuseppe Gallo, Christina Rieger, Dan Engelhard, Thomas Lehrnbecher, Per Ljungman, et al.
Pages: E188 - E199 - Mucorales-specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patients
Authors: Johan Maertens, Roberto D'Amico
Pages: 5416 - 5419 - Biomarker applications in diagnostics of fungal infections
Authors: Johan Maertens
Pages: 173 - 186 - Epidemiology of mucormycosis: review of 18 cases in a tertiary care hospital
Authors: Veroniek Saegeman, Johan Maertens, Nadine Ectors, Wouter Meersseman
Pages: 245 - 254